Germany
Japan
United Kingdom
China
Recombinant Anti-Insulin Receptor alpha (Clone 83-14)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Bovine, Human, Sheep, Pig |
| Conjugation | Unconjugated |
Antibodies
View as table DownloadRecombinant Anti-IL-18 (Clone 125-2H)
| Applications | ELISA, IF, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-p53 (Clone PAb421)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rabbit, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-Notch 2 (Clone B6)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Notch 2 (Clone B9)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Flavivirus group antigen (Clone D1-4G2-4-15 (4G2))
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Dengue virus, West Nile Virus, Yellow Fever Virus |
| Conjugation | Unconjugated |
Recombinant Anti-IL-2 (Clone LNKB-2)
| Applications | ELISA, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Rhodopsin (Clone Rho 1D4)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat, Zebrafish, Cow |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Glucose-dependent insulinotropic Receptor (Clone Gipg013)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse, Rat, Dog |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
| Applications | ELISA, FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-EGFR (Clone S3 12D)
| Applications | ELISA, ICC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD30 (Clone Ki-3)
| Applications | ELISA, FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD30 (Clone Ki-4)
| Applications | ELISA, FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-GPIIb/IIIa (Clone 10E5)
| Applications | ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-EGFR (Clone Matuzumab)
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD81 (Clone 1D6)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Chimpanzee, Goat, Human, Sheep |
| Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | ELISA, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD98 heavy chain (Clone HBJ127)
| Applications | ELISA, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD18 (Clone 1B4)
| Applications | ELISA, FC, IF, IP |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-CR1 (Clone E11)
| Applications | ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-RAGE (Clone 2A11)
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD56 (Clone NCAM12.19)
| Applications | ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Tetraspanin 1 (Clone 4/12)
| Applications | ELISA, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD74 (Clone LN-2)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-CCR5 (Clone T21/8)
| Applications | ELISA, FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CCR5 (phosphoserine 349) (Clone E11/19)
| Applications | ELISA, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CCR5 (phosphoserine 337) (Clone V14/2)
| Applications | ELISA, FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CCR5 (PKC site) (Clone RC-10)
| Applications | ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-Beta 2 adrenergic receptor (Clone 13D6)
| Applications | ELISA, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-H4 K8Ac; K12Ac; K16Ac (Clone KM-2)
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-H3K27me3 (Clone BT164)
| Applications | ELISA, ICC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD32 (Clone IV.3)
| Applications | ELISA, IF, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD163 (Clone 2A10 (2A10/11))
| Applications | ELISA, FC, IF |
| Conjugation | Unconjugated |
Recombinant Anti-MUC1 (Clone HMFG1 (1.10.F3))
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Stat5 phospho Y694 Antibody
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
AKT phospho S473 Antibody
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Active filters
Applications
- IF
Antibody Hosts
- Mouse
Assay Types
- Indirect
Filter by
Category
Target Symbol
- CCR5 (4)
- EGFR (2)
- NOTCH2 (2)
- TNFRSF8 (2)
- ADRB2 (1)
- AGER (1)
- AKT1 (1)
- CD163 (1)
- CD74 (1)
- CD81 (1)
- CR1 (1)
- FCGR2A (1)
- GPR119 (1)
- GROUP ANTIGEN (1)
- H3 (1)
- H4 (1)
- IL18 (1)
- IL2 (1)
- INSR (1)
- ITGA2B (1)
- ITGA5 (1)
- ITGB2 (1)
- MUC1 (1)
- NCAM1 (1)
- RHO (1)
- S (1)
- SLC3A2 (1)
- SNAP25 (1)
- STAT5A (1)
- TNF (1)
- TP53 (1)
- TSPAN1 (1)
- TYRP1 (1)
Reactivities
Clonalities
Conjugates
Modifications
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)